Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.

BMC cancer - 8 Apr 2015

Rodríguez-Vicente Ana E, Quwaider Dalia, Benito Rocío, Misiewicz-Krzeminska Irena, Hernández-Sánchez María, de Coca Alfonso García, Fisac Rosa, Alonso José-María, Zato Carolina, de Paz Juan Francisco, García Juan Luis, Sarasquete Ma Eugenia, Hernández José Ángel, Corchado Juan M, González Marcos, Gutiérrez Norma C, Hernández-Rivas Jesús-María

Abstract excerpt

BACKGROUND: MicroRNAs are known to inhibit gene expression by binding to the 3'UTR of the target transcript. Downregulation of miR-223 has been recently reported to have prognostic significance in CLL. However, there is no evidence of the pathogenetic mechanism of this miRNA in CLL patients. METH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Binding Sites

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Gene Expression Regulation, Neoplastic

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Membrane Glycoproteins

Share to MicroRNAs

Source

Open in PubMed Open full text

Identifiers

PMID: 25880332
DOI: 10.1186/s12885-015-1212-2
PMCID: PMC4404064

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25880332-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.PMID 25880332Read ↗

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.Semantic proximity Read ↗

Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case–control studySemantic proximity Read ↗

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.Semantic proximity Read ↗

Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia.Semantic proximity Read ↗

Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.Semantic proximity Read ↗

miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.Semantic proximity Read ↗

Complexity of miR-223 regulation by CEBPA in human AML.Semantic proximity Read ↗

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemiaSemantic proximity Read ↗

The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia.Semantic proximity Read ↗

CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.Semantic proximity Read ↗

Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFκB pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.